Foods · Fiscal year end Dec 31

Euglena Co., Ltd.

2931

株式会社ユーグレナ

FIGI BBG002F288352931.T2931 JPCorp. no. 8010001112570

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-07

For the first half of the fiscal year to 2026-12: Revenue ¥26.5 billion (+8.0% YoY), Ordinary income ¥1.7 billion (+45.8% YoY), Net income ¥0.1 billion.

	This period	Year on year
Revenue	¥26.5bn	+8.0%
Ordinary profit	¥1.7bn	+45.8%
Net profit to owners	¥73m	—

From the securities report on EDINET, which states no forecast. History via /v1/companies/2931/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-12-31

Revenue: ¥50.4bn
Net income: −¥805m
ROE: —
Equity ratio: 42.7%
Dividend / share: ¥2
Employees: 793

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2025-12-31	¥50.4bn	−¥0.8bn	¥72.3bn	¥28.5bn	—	¥-5.9	¥5.2bn
2024-12-31	¥47.6bn	−¥0.7bn	¥73.3bn	¥32.1bn	—	¥-4.85	¥2.6bn
2023-12-31	¥46.5bn	−¥2.7bn	¥59.6bn	¥20.2bn	—	¥-22.76	¥0.7bn
2022-12-31	¥44.4bn	−¥2.7bn	¥57.3bn	¥19.4bn	—	¥-23.83	¥0.9bn
2021-12-31	¥34.4bn	−¥5.0bn	¥61.0bn	¥20.6bn	—	¥-49.07	¥1.4bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31

Metric	Value	Percentile among listed companies
ROE, %	—	—
Ordinary margin	0.047	35.8
Equity ratio, %	42.7	30.9
Revenue growth	0.0578	54.1
Net income growth	-0.2385	21
Operating cash flow / assets	0.0717	55.5

Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change −3.45pt in 90 days; 3.8% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥27.7bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥138m, 2.7% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/2931/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-03-23: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Segments: Health Care Business, Biofuel Business, Others Business. /v1/companies/2931/segments

Latest voting result: 2026-03-24 · 取締役(監査等委員である取締役を除く。)5名選任の件 · passed. /v1/companies/2931/voting

Ownership changes

All companies →

2026-08-13

Below 5%−3.45pt

Kirei Creation Holdings Inc. cut holdings in Euglena Co., Ltd. (2931) to 4.54% from 7.99%, below the 5% threshold.

S100YW9OFiler profile Original filing (PDF, Japanese)
2026-04-06

Amendment−1.02pt

Kirei Creation Holdings Inc. filed a correction to a 5% report on Euglena Co., Ltd. (2931).

S100XWZ4Filer profile Original filing (PDF, Japanese)
2026-04-03

Decrease−1.15pt

Kirei Creation Holdings Inc. reduced holdings in Euglena Co., Ltd. (2931) to 7.86% from 9.01%.

S100XWVSFiler profile Original filing (PDF, Japanese)
2026-04-03

Amendment−1.15pt

Kirei Creation Holdings Inc. filed a correction to a 5% report on Euglena Co., Ltd. (2931).

S100XWXWFiler profile Original filing (PDF, Japanese)
2025-11-21

Below 5%−1.97pt

Nomura Securities Co.,Ltd. cut holdings in Euglena Co., Ltd. (2931) to 3.43% from 5.40%, below the 5% threshold.

S100X5T2Filer profile Original filing (PDF, Japanese)
2025-11-07

New 5% stake

Nomura Securities Co.,Ltd. disclosed a 5.40% stake in Euglena Co., Ltd. (2931), crossing the 5% reporting threshold.

S100WYWWFiler profile Original filing (PDF, Japanese)
2025-07-07

Below 5%−0.56pt

Nomura Securities Co.,Ltd. cut holdings in Euglena Co., Ltd. (2931) to 4.63% from 5.19%, below the 5% threshold.

S100WBDWFiler profile Original filing (PDF, Japanese)
2025-05-21

Decrease−1.02pt

Kirei Creation Holdings Inc. reduced holdings in Euglena Co., Ltd. (2931) to 9.01% from 10.03%.

S100VQO0Filer profile Original filing (PDF, Japanese)
2025-05-21

Threshold

Holdings of Kirei Creation Holdings Inc. in Euglena Co., Ltd. (2931) moved below 10% (10.03% -> 9.01%).

S100VQO0Filer profile Original filing (PDF, Japanese)
2025-04-22

New 5% stake

Nomura Securities Co.,Ltd. disclosed a 5.19% stake in Euglena Co., Ltd. (2931), crossing the 5% reporting threshold.

S100VNDZFiler profile Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports

Bought SoldHover a dot for the trade

Holder	Period	Net shares	Net % of shares	Avg. filed price	Range
株式会社綺麗創造ホールディングス	2024-02-01 – 2026-08-12	+13,697,125	+10.27pt	¥621.06	¥331–683

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/2931/trades.

5% filings

Large shareholding reports on 2931

Filed	Filer	Stake	Change	Stated purpose
2026-08-13	Kirei Creation Holdings Inc.	4.54%	−3.45pt	—
2026-04-06	Kirei Creation Holdings Inc.	7.99%	−1.02pt	—
2026-04-03	Kirei Creation Holdings Inc.	7.86%	−1.15pt	—
2026-04-03	Kirei Creation Holdings Inc.	7.86%	−1.15pt	—
2025-11-21	Nomura Securities Co.,Ltd.	3.43%	−1.97pt	—
2025-11-07	Nomura Securities Co.,Ltd.	5.40%	—	—
2025-07-07	Nomura Securities Co.,Ltd.	4.63%	−0.56pt	—
2025-05-21	Kirei Creation Holdings Inc.	9.01%	−1.02pt	—
2025-04-22	Nomura Securities Co.,Ltd.	5.19%	—	—
2025-01-27	individual filer	9.20%	−3.72pt	—

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: — issues
Book value: —
Sold in the year: — — issues
Bought in the year: — — issues
Mutual, both reports: 0
Held by listed cos.: 8

Held by: MARUI GROUP CO.,LTD. 8252, ROHTO PHARMACEUTICAL CO.,LTD. 4527, Tokyo Century Corporation 8439, SHIMIZU CORPORATION 1803, CHIYODA CORPORATION 6366, ISUZU MOTORS LIMITED 7202, KITZ CORPORATION 6498, Hitachi, Ltd. 6501

Purposes, all holdings and mutual flags via /v1/companies/2931/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31

Shareholder	Shares	Ratio
individual holder	12,407,692	9.08%
株式会社綺麗創造ホールディングス	11,434,125	8.37%
日本マスタートラスト信託銀行株式会社（信託口）	10,995,400	8.05%
株式会社日本カストディ銀行（信託口）	2,454,200	1.79%
株式会社丸井グループ	2,139,000	1.56%
individual holder	2,001,000	1.46%
楽天証券株式会社共有口	1,571,138	1.15%
individual holder	1,114,000	0.81%
ロート製薬株式会社	1,069,500	0.78%
東京センチュリー株式会社	1,000,000	0.73%

U.S. funds holding 2931

SEC Form N-PORT, reports to 2026-07-31

20 U.S. funds held 4,849,936 shares worth $10.3m.

Fund	Shares	Value	% of fund	As of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS	1,573,058	$3.4m	0.001%	2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS	986,125	$2.0m	0.001%	2026-06-30
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS	711,100	$1.5m	0.004%	2026-06-30
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS	455,700	$1.0m	0.007%	2026-07-31
Schwab International Small-Cap Equity ETF SCHWAB STRATEGIC TRUST	241,545	$0.6m	0.010%	2026-05-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/2931
GET /v1/companies/2931/financials
GET /v1/companies/2931/details
GET /v1/companies/2931/segments
GET /v1/companies/2931/voting
GET /v1/companies/2931/tender-offers
GET /v1/companies/2931/indicators
GET /v1/companies/2931/earnings-releases
GET /v1/events?ticker=2931
GET /v1/companies/2931/trades         
GET /v1/companies/2931/cross-holdings 
GET /v1/companies/2931/brief

Plans from $9 a month · Documentation